Skip to content

It takes more than medicine...

  • Instagram
  • Vimeo
  • Linkedin

8607 Roberts Drive, Suite 150 Sandy Springs, GA 30350-2237

(770) 518-8272phone    (770) 518-3310fax

8607 Roberts Drive, Suite 150 Sandy Springs, GA 30350-2237


Horizons in Hemophilia, December 2014


A New Year Awaits Us - 2014 Remembered

As I write my final year-end article for the newsletter, I can’t help but think of the cold days that lie ahead and the fact that we’ll be celebrating a very special new year at HoG; a year that will bring new leadership to an organization that has never strayed from its mission and, because of you, has had outstanding vision.


FDA Approves Emory-developed Hemophilia Drug

Last month the Food and Drug Administration approved Obizur, a treatment for acquired hemophilia A that was originally developed by a research team led by Emory hematologist Pete Lollar, Hemophilia of Georgia Professor of Pediatrics.


2014 Volunteer Year in Review

As 2014 is coming to a close, we reflect back on all of the wonderful accomplishments achieved during the year. Here at Hemophilia of Georgia, many of these accomplishments would not have been possible without the support of our kind and generous volunteers.


Day of Generosity Kicks Off a Season of Giving

You made a difference! Tens of thousands of Georgians donated more than $2.3 million to nonprofits close to their hearts on Georgia Gives Day, Thursday, November 13, and Hemophilia of Georgia was a proud recipient of many gifts that day.


Board Member Spotlight: Meet Tom Singh

After reading the subject of this article, you might just be saying to yourself, “This must be the third Board Member Spotlight I’ve read this year.” And, you’d be right! So, without further ado, it is my pleasure to introduce you to Tom Singh; our newest Board Member.


Factor In Winter Weather

The HoG pharmacies use Federal Express and UPS to deliver pharmacy orders.  Bad weather in other states can cause delivery delays.


MASAC Issues Advisory on Possible Increased Risk of Inhibitors to Factor VIII

The Medical and Scientific Advisory Council (MASAC) of the National Hemophilia Foundation has issued a Medical Advisory concerning the risk of inhibitor development from a recombinant factor VIII product.


Holiday Hours

For a list of holiday hours please click on the headline link above.


View the clinic schedules for the Georgia Hemophilia Treatment Centers.

Have you read HoG's Blog?

Hemophilia of Georgia Facebook       Hemophilia of Georgia Twitter       Donate Now